Nuvation Bio
NUVB
NUVB
148 hedge funds and large institutions have $447M invested in Nuvation Bio in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 46 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
18% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 39
0.17% more ownership
Funds ownership: 61.75% → 61.92% (+0.17%)
9% less capital invested
Capital invested by funds: $490M → $447M (-$43.1M)
Holders
148
Holding in Top 10
4
Calls
$30K
Puts
$20K
Top Buyers
| 1 | +$20.3M | |
| 2 | +$10.8M | |
| 3 | +$7.62M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$4.65M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$3.36M |
Top Sellers
| 1 | -$3.32M | |
| 2 | -$2.75M | |
| 3 | -$2.33M | |
| 4 |
D.E. Shaw & Co
New York
|
-$2.01M |
| 5 |
SCM
Sio Capital Management
New York
|
-$1.95M |